Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases. Academic Article uri icon

Overview

abstract

  • OBJECTIVE: The aim of this study was to investigate the key molecular alterations in small primary pancreatic neuroendocrine tumors (PanNETs) associated with the development of liver metastases. BACKGROUND: Well-differentiated PanNETs with small size are typically indolent; however, a limited subset metastasize to the liver. METHODS: A total of 87 small primary PanNETs (<3 cm), including 32 metastatic cases and 55 nonmetastatic cases after a 5-year follow-up, were immunolabeled for DAXX/ATRX and analyzed for alternative lengthening of telomeres (ALT) by Fluorescence In Situ Hybridization. A subset of these cases, 24 that metastasized and 24 that did not metastasize, were assessed by targeted next-generation sequencing and whole-genome copy number variation. RESULTS: In the entire cohort, high Ki-67 (OR 1.369; 95% CI 1.121-1.673; P = 0.002), N-stage (OR 4.568; 95% CI 1.458-14.312; P = 0.009), and ALT-positivity (OR 3.486; 95% CI 1.093-11.115; P = 0.035) were independently associated with liver metastases. In the subset assessed by next-generation sequencing and copy number variation analysis, 3 molecular subtypes with differing risks of liver metastases were identified. Group 1 (n = 15; 73% metastasized) was characterized by recurrent chromosomal gains, CN-LOH, DAXX mutations, and ALT-positivity. Group 2 (n = 19; 42% metastasized, including 5 G1 tumors) was characterized by limited copy number alterations and mutations. Group 3 (n = 14; 35% metastasized) were defined by chromosome 11 loss. CONCLUSIONS: We identified genomic patterns of small PanNETs associated with a different risk for liver metastases. Molecular alterations, such as DAXX mutations, chromosomal gains, and ALT, are associated with an increased risk of metastasis in small PanNETs. Therefore, targeted sequencing and/or ALT analysis may help in the clinical decisions for these small PanNETs.

authors

  • Pea, Antonio
  • Yu, Jun
  • Marchionni, Luigi
  • Noe, Michael
  • Luchini, Claudio
  • Pulvirenti, Alessandra
  • de Wilde, Roeland F
  • Brosens, Lodewijk A
  • Rezaee, Neda
  • Javed, Ammar
  • Chianchiano, Peter
  • Gobbo, Stefano
  • Regi, Paolo
  • Salvia, Roberto
  • Bassi, Claudio
  • He, Jin
  • Weiss, Matthew J
  • Cameron, John L
  • Offerhaus, G Johan A
  • Hruban, Ralph H
  • Lawlor, Rita T
  • Scarpa, Aldo
  • Heaphy, Christopher M
  • Wood, Laura D
  • Wolfgang, Christopher L

publication date

  • March 1, 2020

Research

keywords

  • Liver Neoplasms
  • Neuroendocrine Tumors
  • Pancreatic Neoplasms

Identity

PubMed Central ID

  • PMC6565500

Scopus Document Identifier

  • 85079891962

Digital Object Identifier (DOI)

  • 10.1097/SLA.0000000000003022

PubMed ID

  • 30339629

Additional Document Info

volume

  • 271

issue

  • 3